Delivering safer immunotherapies for cancer

Delivering safer immunotherapies for cancer

Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new drug approvals and a massive pipeline of additional treatments in clinical and preclinical development. However, modulation of the immune system can be a double-edged sword: Drugs that activate immune effectors...

Full description

Bibliographic Details
Main Authors: Milling, Lauren Elizabeth (Contributor), Irvine, Darrell J (Contributor), Zhang, Yuan, Ph. D. Massachusetts Institute of Technology (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Materials Science and Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Elsevier BV, 2018-09-13T19:56:40Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items